SOL (SOL) Stock Overview

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home care activities and related medical equipment in Italy and internationally. The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids. In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services. Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples. Its products are used in the chemical, electronics, steel, metal, and foodstuff industries, as well as in environmental protection, and research and healthcare sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Stichting Airvision BV.